Feb 1st, 2018
Novo Nordisk CEO Is 'Quite Optimistic' About 2018 Growth
Lars Fruergaard Jorgensen, chief executive officer at Novo Nordisk, discusses what he calls "strong momentum" for the company, the impact of the U.S., tax cut, and their M&A outlook after being outbid for Ablynx. He speaks with Bloomberg's Matt Miller on “Bloomberg Markets: European Open.” (Source: Bloomberg)
